Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1462-1466

  Poczatek, Robert B ^b   Myers, Russell B ^b   Manne, Upender ^b   Oelschlager, Denise K ^b   Weiss, Heidi L ^b   Bostwick, David G ^b   Grizzle, William E ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

Cell adhesion; Prostatic intraepithelial neoplasia; Prostatic neoplasms

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; CARCINOGENESIS; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SCORING SYSTEM;

EID: 0032875591     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68341-3     Document Type: Article

References (24)

1. Mettlin, C. J. and Murphy, G.: The national cancer data base report on prostate cancer. Cancer, 74: 1640, 1994.
2. The Veterans Administration Co-Operative Urological Research Group.: Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet., 124: 1011, 1967.
3. Logothetis, C. J.: Management of androgen independent prostate carcinoma. In: Prostate Diseases. Edited by H. Lepor and R. K. Lawson. Philadelphia: W. B. Saunders Co., chapt. 28, pp. 364-367, 1993.
4. Goodwin, R. A., Tuttle, S. E., Bucci, D. M., Jewell, S. D., Martin, E. W. and Steplewski, Z.: Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A. Am. J. Clin. Pathol., 88: 462, 1987.
5. Tandon, A. K., Clark, G. M., Chamness, G. C. and McGuire, W. L.: Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res., 50: 3317, 1990.
6. Kievit, E., Pinedo, H. M., Schluper, H. M., Haisma, H. J. and Boven, E.: Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumor uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts. Br. J. Cancer, 73: 457, 1996.
7. Litvinov, S. V., Velders, M. P., Bakker, H. A., Fleuren, G. J. and Warnaar, S. O.: Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J. Cell Biol., 125: 437, 1994.
8. Velders, M. P., van Rhijn, C. M., Briaire, I. H., Fleuren, G. J., Warnaar, S. O. and Vitvinov, S. V.: Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model. Cancer Res., 55: 4398, 1995.
9. Riethmuller, G., Schneider-Gadicke, E., Schlimok, G., Schmiegel, W., Raab, R., Hoffken, K., Gruber, R., Pichlmaier, H., Hirche, H. and Pichlmayr, R.: Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group [see comments]. Lancet, 343: 1177, 1994.
10. Myers, R. B., Meredith, R. F., Schlom, J., LoBuglio, A. F., Bueschen, A. J., Wheeler, R. H., Stockard, C. R. and Grizzle, W. E.: Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas. J. Urol., 152: 243, 1994.
11. Grizzle, W. E., Myers, R. B., Manne, U. and Srivastava, S.: Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: John Walker's Methods in Molecular Medicine - Tumor Marker Protocols. Edited by M. Hanausek and Z. Walaszek. Totowa, NJ: Humana Press, Inc., pp. 143-160, 1998.
12. Bostwick, D. G. and Brawer, M. K.: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer, 59: 788, 1987.
13. erbB-2 and c-erbB-2 mRNA in the prostatic cell line LNCaP. J Steroid Biochem. Molec. Biol., 59: 441, 1996.
14. Grizzle, W. E., Myers, R. B., Manne, U., Stockard, C. R., Harkins, L. E. and Srivastava, S.: Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia. In: John Walker's Methods in Molecular Medicine - Tumor Marker Protocols. Edited by M. Hanausek and Z. Walaszek. Totowa, NJ: Humana Press, Inc., pp. 161-179, 1998.
15. Ragnhammar, P., Fagerberg, J., Frodin, J. E., Hjelm, A. L., Lindermalm, C. Magnusson, I., Masucci, G. and Mellstedt, H.: Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma-long-lasting, complete remissions can be induced. Int. J. Cancer, 53: 751, 1993.
16. Meredith, R. F., Khazaeli, M. B., Plott, W. E., Spencer, S. A., Wheeler, R. H., Brady, L. W., Woo, D. V. and LoBuglio, A. F.: Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer. J. Nucl. Med., 36: 2229, 1995.
17. erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. Natl. Cancer Inst., 86: 1140, 1994.
18. Myers, R. B., Schlom, J., Srivastava, S. and Grizzle, W. E.: Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Mod. Pathol., 8: 260, 1995.
19. Qian, J., Jenkins, R. B. and Bostwick, D. G.: Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization. Eur. Urol., 30: 177, 1996.
20. Qian, J., Bostwick, D. G., Takahashi, S., Borell, T. J., Herath, J. F., Leiber, M. M. and Jenkins, R. B.: Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 55: 5408, 1995.
21. Myers, R. B., Srivastava, S., Oelschlager, D. K., Brown, D. and Grizzle, W. E.: Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma. Hum. Pathol., 27: 1021, 1996.
22. Myers, R. B. and Grizzle, W. E.: Biomarker expression in prostatic intraepithelial neoplasia. Eur. Urol., 30: 153, 1996.
23. Roye, G. D., Myers, R. B., Brown, D., Poczatek, R., Beenken, S. W. and Grizzle, W. E.: CD44 expression in dysplastic epithelium and squamous cell carcinoma of the esophagus. Int. J. Cancer (Pred. Oncol. ), 69: 254, 1996.
24. Benchimol, S., Fuks, A., Jothy, S., Beauchemin, N., Shirota, K. and Stanners, C. P.: Carcinoembryonic antigen functions as an intracellular adhesion molecule. Cell, 57: 327, 1989.